DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
The generic ingredient in KIONEX is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
Profile for product number 001
|Active Rx/OTC/Discontinued:||RX||Dosage:||POWDER;ORAL, RECTAL||Strength||454GM/BOT|
|Approval Date:||Feb 6, 1998||TE:||AA||RLD:||No|
Complete Access Available with Subscription